A federal judge in Illinois allowed a class action against Biogen Inc. to advance over the drugmaker’s alleged collusion with ...
Biogen (NASDAQ: BIIB) will, this week, present data at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Barcelona, Spain, demonstrating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results